Social Media Giveaways Turn Unlicensed Weight-Loss Drugs into "Prizes"
A growing trend on social media platforms has seen hidden-market promoters offering powerful, unlicensed weight-loss drugs as prizes in online giveaways. These competitions often claim that participants have only a short time to enter and that the winner will receive an unlicensed medicine without any medical oversight.
The giveaway campaigns are run by WhatsApp and Telegram groups, many of which promise "biggest giveaways yet" and offer unapproved medicines such as retatrutide – an experimental weight-loss drug not approved for use anywhere in the world. The groups often claim that participants can win these medications through random draws or contests where only a few hours are left to enter.
However, experts warn that these campaigns pose significant health risks due to the lack of safety checks and quality controls associated with unlicensed pharmaceuticals. Dr Emily Rickard, research fellow at the University of Bath, described these giveaways as "extremely dangerous" tactics used to promote powerful drugs without any clinical oversight.
Regulatory agencies in the UK have laws that restrict the sale and distribution of prescription-only medicines, including those aimed at weight loss. However, promoters using social media platforms are attempting to bypass these regulations by disguising their operations under the guise of coaching or training services.
One company, operating as BioBlue Fitness, has been found to be selling unlicensed weight-loss drugs through its platform, despite advertising it as an exercise program. Potential customers are often misdirected when inquiring about workouts and instead find themselves being referred to unapproved medications.
When confronted with the issue, administrators of this platform revealed that the system is designed to sell these substances without any regard for safety or efficacy. By applying high-pressure tactics such as countdown timers and raffles, promoters aim to encourage people to disregard caution and participate in giving away powerful medicines without proper medical oversight.
In response to concerns raised by users, Meta – which owns WhatsApp – has stated that accounts breaking the messaging guidelines would be banned. However, Telegram also explicitly prohibits the sale of unlicensed medication on its platform, with administrators actively working to remove such content whenever discovered.
As these hidden-market promoters continue to use social media platforms to give away unlicensed weight-loss drugs, regulatory agencies must take proactive steps to prevent this trend from further spreading and put safety first in protecting public health.
A growing trend on social media platforms has seen hidden-market promoters offering powerful, unlicensed weight-loss drugs as prizes in online giveaways. These competitions often claim that participants have only a short time to enter and that the winner will receive an unlicensed medicine without any medical oversight.
The giveaway campaigns are run by WhatsApp and Telegram groups, many of which promise "biggest giveaways yet" and offer unapproved medicines such as retatrutide – an experimental weight-loss drug not approved for use anywhere in the world. The groups often claim that participants can win these medications through random draws or contests where only a few hours are left to enter.
However, experts warn that these campaigns pose significant health risks due to the lack of safety checks and quality controls associated with unlicensed pharmaceuticals. Dr Emily Rickard, research fellow at the University of Bath, described these giveaways as "extremely dangerous" tactics used to promote powerful drugs without any clinical oversight.
Regulatory agencies in the UK have laws that restrict the sale and distribution of prescription-only medicines, including those aimed at weight loss. However, promoters using social media platforms are attempting to bypass these regulations by disguising their operations under the guise of coaching or training services.
One company, operating as BioBlue Fitness, has been found to be selling unlicensed weight-loss drugs through its platform, despite advertising it as an exercise program. Potential customers are often misdirected when inquiring about workouts and instead find themselves being referred to unapproved medications.
When confronted with the issue, administrators of this platform revealed that the system is designed to sell these substances without any regard for safety or efficacy. By applying high-pressure tactics such as countdown timers and raffles, promoters aim to encourage people to disregard caution and participate in giving away powerful medicines without proper medical oversight.
In response to concerns raised by users, Meta – which owns WhatsApp – has stated that accounts breaking the messaging guidelines would be banned. However, Telegram also explicitly prohibits the sale of unlicensed medication on its platform, with administrators actively working to remove such content whenever discovered.
As these hidden-market promoters continue to use social media platforms to give away unlicensed weight-loss drugs, regulatory agencies must take proactive steps to prevent this trend from further spreading and put safety first in protecting public health.